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A B S T R A C T
Purpose: To document the clinical characteristics and inheritance pattern of epilepsy in multigeneration
Algerian families.
Methods: Affected members from extended families with familial epilepsy were assessed at the
University Hospital of Oran in Algeria. Available medical records, neurological examination,
electroencephalography and imaging data were reviewed. The epilepsy type was classiﬁed according
to the criteria of the International League Against Epilepsy and modes of inheritance were deduced from
pedigree analysis.
Results: The study population included 40 probands; 23 male (57.5%) and 17 female subjects (42.5%).
The mean age of seizure onset was 9.5  6.1 years. According to seizure onset, 16 patients (40%) had focal
seizures and 20 (50%) had generalized seizures. Seizure control was achieved for two patients (5%) for
10 years, while 28 (70%) were seizure-free for 3 months. Eleven patients (27.5%) had prior febrile seizures,
12 were diagnosed with psychiatric disorders and four families had syndromic epilepsy. The consanguinity
rate among parents of affected was 50% with phenotypic concordance observed in 25 families (62.5%).
Pedigree analysis suggested autosomal dominant (AD) inheritance with or without reduced penetrance in
18 families (45%), probable autosomal recessive (AR) inheritance in 14 families (35%), and an X-linked
recessive inheritance in one family.
Conclusion: This study reveals large Algerian families with multigenerational inheritance of epilepsy.
Molecular testing such as exome sequencing would clarify the genetic basis of epilepsy in some of our
families.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Epilepsy is the most common neurological condition, affecting
more than 50 million people in the world, with a 3% risk of
developing epilepsy across all ages [1,2]. A genetic contribution to
epilepsy has been recognized since Antiquity and is well
established through twin studies [3–5]. Family studies have also
suggested the involvement of genetic factors in different forms of
generalized and partial epilepsies, showing a higher risk of
epilepsy in proband’s ﬁrst-degree relatives (children, siblings
and parents) as compared to the general population [6,7].* Corresponding author. Tel.: +213 554650521; fax: +213 41465869.
E-mail address: amina.chentouf@yahoo.com (A. Chentouf).
http://dx.doi.org/10.1016/j.seizure.2015.06.015
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reDuring the past three years, novel technologies and an
unprecedented level of international collaboration has resulted in
the discovery of novel genes for monogenic epilepsies. Indeed, the
use of massive parallel sequencing technologies has allowed for the
identiﬁcation of PRRT2 as the long-sought gene for Benign Familial
Infantile Seizures (BFIS) [8,9], and the KCNT1 mutations in Malignant
Migrating Partial Seizures of Infancy (MMPSI) and severe Autosomal
Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) [10,11]. In
addition, we have recently identiﬁed a novel gene in one family
with monozygotic twins affected by temporal lobe epilepsy.
Exome sequencing revealed a novel de novo mutation (p.A39E) in
the galanin gene, which acts as a potent anticonvulsant and regulate
epileptic seizures in animal models. Functional analysis of the
mutant galanin peptide showed antagonist effects on galanin
receptor 1 (GalR1) and reduced agonist effects on GalR2. Theseserved.
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ment of anti-epileptic treatment [12].
During our ﬁeldwork, we have identiﬁed many additional
families with several members affected with epilepsy. While
consanguineous marriages comprise 22–39% [13–15] of all mar-
riages in Algeria, which may predispose offspring to rare autosomal
recessive conditions, to our knowledge, there have been no reports
describing the inheritance patterns of familial epilepsy in Algeria.
In this paper, we present genealogical analysis, clinical char-
acteristics and the probable patterns of inheritance in 40 Algerian
families with epilepsy in order to perform further genetic analysis
for the detection of the pathogenic variation that may help in carrier
detection and family planning.
2. Materials and methods
2.1. Family recruitment, inclusion criteria and clinical evaluation
This is a prospective study done at the Neurology Department at
Oran University Hospital, which is the main regional hospital in
Oran, from June 2011 to June 2014. Families were included when
their past history showed that there are other affected members in
the extended family.
All possibly affected individuals available underwent clinical
evaluation; and whenever possible, EEG and MRI were performed.
A bilingual trained psychiatrist (French-Arabic) assessed individu-
als with psychiatric disorders using the Mini International
Neuropsychiatric Interview (MINI).
Forty families agreed to participate in the study. A three-
generation pedigree with details regarding seizures, congenital
malformations, comorbidities and consanguinity in parents was
drawn for each family using ‘‘Genial Pedigree’’ software (http://
www.pedigreedraw.com/), through a structured interview that
took 50–60 min. Interviews were done either on the telephone or
in person and responses were crosschecked with family members
who were invited to participate in the study.
We excluded from the study ﬁve patients for whom a parent
was not available due to death, divorce or other reasons leading to
inability to take full family history and difﬁculty in constructing
a pedigree.
Pedigree analysis concluded that the inheritance pattern in a
family was classiﬁed as autosomal dominant if there were multiple
generations affected in a vertical pattern, and if both males and
females were affected. It was classiﬁed as autosomal recessive if
the affected individuals were seen in only one generation in a
horizontal pattern, if males and females were affected and if
parents were related. It was classiﬁed as X-linked recessive if only
males were affected, if the affected males were related through
putative carrier females, and if there was no male-to-male
transmission. Considering the possibility of endogamous mar-
riages, we proposed AR as the probable mode of inheritance when
there were multiple affected in a sibship with non-affected parents
who both originate from the same small village.
2.2. Seizure type and epileptic syndrome identiﬁcation
We obtained information regarding seizure manifestations from
patients as well as observers. We reviewed all available medical
records, neurological examination, electroencephalography and
imaging data. Based on the combined results, each patient’s epilepsy
was characterized, and whenever possible, classiﬁed.
2.3. Deﬁnitions
Seizures and epilepsy syndromes were classiﬁed according to
the International League against epilepsy recommendations[16,17]. Families were classiﬁed according to the proband’s
epilepsy syndrome. To ensure comparability with previous studies
on the same ﬁeld, we did not use the recommendations of the ILAE/
2010 classiﬁcation for seizures and epilepsies.
The proband was deﬁned as the ﬁrst affected family member
who sought medical attention at hospital and met the inclusion
and exclusion criteria.
We considered as ‘‘familial epilepsy’’ the occurrence of epilepsy
in at least two members of the same family including the proband.
First-degree relatives comprised parents, siblings, and children;
second-degree relatives comprised grandparents, aunts, and
uncles; and third-degree relatives comprised ﬁrst cousins.
In clinical genetics, consanguinity is deﬁned as a marital
relationship between two individuals who share the same ancestor
and the degree of consanguinity is not beyond second cousins. In this
study, however, further genetic relations were also considered when
assessing the mode of inheritance in order to include any possible
founder mutations in this highly consanguineous population.
Families are deﬁned as phenotypically concordant if all affected
relatives have the same clinical feature (epileptic syndrome or
seizure type, age at onset, response to treatment and EEG ﬁndings).
Age of onset was deﬁned as the age when the patient, his/her
family members or friends ﬁrst noticed the disease. We deﬁned
controlled epilepsy as the absence of seizures for at least six months.
The likely modes of inheritance were based on the family
pedigree that was documented in the ﬁle.
The purpose of the study was explained to the patient/family
and informed consent was obtained from patients, parents or legal
guardians.
2.4. Statistical analysis
The collected data were coded and entered into the SPSS
21.0 for Mac OS X. We conducted a descriptive analysis of cases
involving the calculation of averages and standard deviations for
quantitative variables and percentages for categorical variables.
3. Results
3.1. Family features
Forty families with two or more members affected by idiopathic
epilepsy participated in the study. We collected data from
907 subjects, of whom 156 (17.2%) showed epilepsy. The mean
number of individuals (both with and without epilepsy) was
22.7per family with a mean of 4-affected individuals per family.
In addition to the 40 probands, 61 ﬁrst-, 17 second- and
19 third-degree relatives had epilepsy. In the collected sample,
only two sets of monozygotic twins were present. Consanguinity
was reported among parents in 20 out of 40 families with 16 (40%)
ﬁrst cousins and 4 (10%) second cousins. In 25 families (62.5%)
affected members shared the same phenotype for epilepsy, while
the others appeared to have a range of different phenotypes.
With regard to epileptic features in general, pedigrees were
compatible with autosomal dominant (AD) inheritance with or
without reduced penetrance in 18 families (45%). In 14 families
(35%), an autosomal recessive (AR) transmission could also be
hypothesized, and an X-linked recessive inheritance (XR) was
assigned in only one family. In the remaining families, the pedigree
analysis was inconclusive or suggested more than one possible
mode of inheritance (Fig. 1a and b).
3.2. Probands clinical data
There were 23 male (57.5%) and 17 female subjects (42.5%)
in the study group, with ages ranging from 4 to 59 years (mean
Fig. 1. Pedigrees of the 40 families.
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were over 18 years). The age of seizure onset ranged from three
months to 22 years (mean: 9.5  6.1 years). According to seizure
onset, 16 patients (40%) had focal seizures and 20 (50%) had
generalized seizures. The remaining four patients (10%) could not be
classiﬁed as having either focal or generalized seizures because both
partial and generalized onset seizures were noted.
Among all probands, 11 (27.5%) had prior febrile seizures (FS)
and 8 of them (72.7%) had family history of FS.
The distribution of probands with respect to ILAE epilepsy
syndrome diagnosis is summarized in Table 1.
Twenty-four patients (60%) were on monotherapy, twelve
(30%) were on two antiepileptic medications, and two (5%) were onTable 1
Clinical features, EEG ﬁndings and the probable modes of inheritance in the 40 familie
Proband according
to family number
Age at onset (years)Seizure type Epilepsy
syndrome
EEG ﬁndin
1 (Galanin family)13 Complex partial FTLE Focal tem
spikes
2 15 Myoclonic JME Generalize
3 18 Simple partial FTLE Focal slow
4 18 Myoclonic JME Generalize
5 10 Myoclonic EPM1 Generalize
waves pho
6 5 Absence CAE Generalize
7 15 Complex partial FTLE Central an
8 11 Myoclonic JME Generalize
9 11 Myoclonic EPM1 Diffuse sp
10 2 Myoclonic GEFS+ Photosens
11 3 Generalized
tonic-clonic
GEFS+ Generalize
12 4 Unknown GEFS+ Focal tem
epileptic a
13 5 Myoclonic JME Generalize
14 11 Generalised tonic clonicUnclassiﬁedNormal 
15 5 Complex partial GEFS+ Focal pari
16 16 Complex partial FTLE Focal spik
region
17 4 Generalised
tonic clonic
GEFS+ Diffuse slo
18 1 Simple partial FTLE Frontal an
19 1 Generalised tonic clonicGEFS+ Focal tem
20 12 Complex partial GEFS+ Temporal 
21 17 Myoclonic JME Generalize
22 17 Myoclonic JME Generalize
23 16 Complex partial FTLE Temporo-
24 6 Myoclonic EPM1 Generalize
25 9 Myoclonic JME Generalize
26 22 Unknown UnclassiﬁedNormal 
27 9 Myoclonic JME Generalize
28 15 Complex partial UnclassiﬁedSlow wav
29 3 Complex partial FTLE Temporal 
30 10 Complex partial FTLE Fronto-tem
31 1 Simple partial GEFS+ Generalize
32 8 Myoclonic JME Spike wav
33 1 Myoclonic JME Generalize
34 12 Complex partial FTLE Focal spik
35 4 Unknown FTLE Normal 
36 15 Generalized
tonic clonic
FTLE Normal 
37 19 Simple partial FTLE Temporal 
38 1 Unknown UnclassiﬁedMultifocal
39 4 Complex partial FTLE Temporal 
40 14 Complex partial GEFS+ Frontal ep
AD: Autosomal dominant, AR: autosomal recessive, XR: X-linked recessive, CAE: childhoo
epilepsy type 1, GEFS+: genetic epilepsy with febrile seizure plus, FTLE: familial tempo
disorder.three antiepileptic drugs. The most common antiepileptic medica-
tions used were valproic acid (22/40, 55%), carbamazepin (11/40,
27.5%) and levetiracetam (8/40, 20%).
At the time of analysis, seizure control was achieved in
21 patients (52.5%) using mono or polytherapy. 28 (70%) were
seizure-free for 3 months and two (5%) have been weaned for
10 years. The other twelve patients (30%) continued to experience
seizures despite trials of several antiepileptic medications.
Two probands were diagnosed with intellectual disability and
12 with a psychiatric comorbidity: 4 with depression, 6 with
anxiety, one with attention deﬁcit hyperactivity disorder (ADHD)
and one with schizophrenia; all were under psychiatrist follow up
(AD).s.
gs Neurological
examination
Probable mode of
inheritance
poral Normal De novo [15]
d polyspikes Normal AD reduced penetrance
 waves Normal AD reduced penetrance
d polyspikes Normal AD reduced penetrance? AR?
d Polyspikes and
tosensitivity
Dysarthria, ataxia AR
d 3 Hz spike waves Normal AR
d temporo-parietal spikes Normal AD
d polyspikes waves Normal XR? AD with reduced
penetrance?
ikes and polyspikes Cerebellar
ataxia, ID
AR
itivity Normal AD reduced penetrance? AR?
d spike waves Normal AD
poro-parietal
ctivity
Normal AR
d polyspikes Normal AR
Blindness,
deafness, ID
AR
eto-occipital epileptic activityNormal AD reduced penetrance
es in temporo-parietal Normal AD reduced penetrance
wing Spastic paraplegia IDAD
d temporal spikes Normal AD
poro-parietal spikes Normal AD? AR?
spike-waves Normal AD
d polyspikes Normal AR
d polyspikes Normal AR
occipital spikes Blindness AD
d polyspikes Dysarthria, ataxia ID AR
d polyspikes Normal AR
Normal AD
d polyspikes Normal AD reduced penetrance? AR?
es in occipital regions Normal AD reduced penetrance? AR?
epileptic activity Normal AD?
poral spikes Normal XR
d epileptic activity Normal AR
es in frontal region Normal AD variable penetrance
d polyspikes Normal AD
es in temporal region Normal AD? AR?
Normal AD variable penetrance
Normal AD
spikes Normal AD
 spikes Microcephaly ID AD variable penetrance
and occipital spikes Normal AD
ileptic activity Normal AD
d absence epilepsy, JME: juvenile myoclonic epilepsy, EPM1: progressive myoclonic
ral lobe epilepsy, ID: intellectual disability, ADHD: attention deﬁcit hyperactivity
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the probable modes of inheritance are summarized in Table 1.
Brain imaging (CT scan or MRI) was normal in all cases.
In families 5,9,14 and 24, epilepsy was associated with other
manifestations such as intellectual disability, ataxia and blindness,
probably due to undiagnosed autosomal recessive syndromes
(Table 1).
4. Discussion
Familial epilepsy encompasses several different syndromes,
which are generally diagnosed by clinical features. The key
element in making the correct diagnosis is obtaining a compre-
hensive clinical history and establishing a detailed pedigree.
The availability of extensive genealogical data can provide large
pedigrees, potentially very informative for genetic analysis.
We present here the clinical proﬁle and inheritance pattern of
familial idiopathic epilepsies in Algerian families. In this study, the
population sample was taken from Oran, the major city on the
northwestern Mediterranean coast of Algeria with a population of
approximately 1,500,000. Many of our patients originate from Sidi
Ali, a small village about 80 km away from Oran. Previous reports
have ascertained a high rate of consanguineous unions of up to 34%
in Tlemcen, a region about 150 km away from Oran [13]. Given the
existence of numerous large and multigenerational pedigrees with
several affected members, the Oran are thus emerging as an
interesting population for genetic research on the epilepsies.
In this study, 40% of parents of affected individuals were ﬁrst
cousins. This is in line with the results of a recent study conducted
in Oran and which recognized parental consanguinity as signiﬁ-
cant risk factor for both monogenic and polygenic epilepsies
(p = 0.029) [18].
Similar results have been reported in other inbreeding
populations. For instance, Masri et al. reported a high rate of
parental consanguinity (61.3%) among 31 Jordanian families with
familial childhood epilepsy [19]. Premarital counselling for couples
who have a family history of epilepsy is recommended.
Epilepsy was more frequent in ﬁrst- than in second-degree
relatives. We have already shown in a previous study involving
subjects belonging to the same region that family history of
epilepsy in ﬁrst-degree relatives increased signiﬁcantly the risk of
developing epilepsy (p < 104) [18]. Similarly, in a large Turkish
cohort of 3098 epileptic patients, 19.9% had at least one epileptic
family member with ﬁrst-degree relatives being twice more
affected than second-degree relatives (202/94) [20].
Most families (62.5%) shared the same phenotype while the
remaining appeared to have a range of different epilepsy
phenotypes. This ﬁnding could have two possible interpretations:
It could be that certain variants may predispose to a relatively
narrow clinical phenotype while others result in a much more
varied phenotype or that this clinical heterogeneity could reﬂect
the possibility that individuals within some families may possess
additional genetic variants or share non-genetic factors that
inﬂuence phenotypic expression.
In our study population, there was a slight male predominance
of 23M/17F. Most studies of epilepsy indicate that males are more
frequently affected than females, although the difference is seldom
statistically signiﬁcant [21].
The mean age at seizure onset was around 10 years, probably
because of the predominance in our sample of epilepsy syndromes
starting in adolescence or later, such as juvenile myoclonic
epilepsy [22], progressive myoclonic epilepsy [23,24], and familial
temporal lobe epilepsy [25].
Among probands, 40% had partial seizures and 50% had
generalized seizures. This is in agreement with studies from the
Arab countries, which had found partial seizures less common thangeneralized seizures [26] matching Asian and sub-Saharan African
studies [27,28]. In USA, Abou Khalil reported that patients with
generalized epilepsy were more likely to have ﬁrst and second
degree relatives with than those with partial epilepsy (40.2%
versus 31.2%, p = 0.001) [29].
Prior febrile seizures (FS) were reported among 11 probands
(27.5%), and three quarters of them had a family history of FS.
These results are consistent with those of Abou Khalil et al., who
reported that epileptic patients with prior FS were more likely to
have a family history of FS than those without prior FS
(p < 0.000001). In a multivariate analysis, Hwang identiﬁed family
history of epilepsy as a signiﬁcant predictor of unprovoked
seizures after FS (p = 0.019) [30]. This ﬁnding suggests that FS
represent an early expression of a low seizure threshold in patients
genetically predisposed to epilepsy. Indeed, FS can be the gateway
to numerous genetic epileptic syndromes such as Genetic Epilepsy
with Febrile Seizures Plus (GEFS+) [31], epileptic syndrome by
febrile infection (FIRES) [32], severe myoclonic epilepsy in infancy
(SMEI) [33] and temporal lobe epilepsy (TLE) [29,34].
Only 60% were seizure-free for three months, while 40%
continued experiencing seizures. This could be explained by the
fact that many patients had myoclonic epilepsy (juvenile or
progressive) known to be drug-resistant or drug dependant. It
should also be noted that some patients did not observe correctly
the prescribed treatment.
Psychiatric comorbidities were reported among 12 probands
(30%). In recent years, several studies have shown clear links
between epilepsy and various neuropsychiatric disorders includ-
ing psychosis and depression. Rates of mood disorders ranged from
25% to 48% and anxiety disorders from 14% to 31% [35,36]. Rates of
major depressive episodes are increased in patients with epilepsy
and range from 11% to 62%, compared with 3.7% to 6.7% for the
general population [37]. Furthermore, the percentage of deaths by
suicide in patients with epilepsy ranges from 11% to 33%, with an
overall average of 11.5% [38]. The association of epilepsy with
psychosis is also striking, where the prevalence of the interictal
psychosis of epilepsy ranges in different studies between 4.3% and
44%. In a recent review, rates of 19.4% and 15.2% in generalized
epilepsies (GE) and TLE groups, respectively, were reported [39].
Very recently, it has become clear that neuropsychiatric
disorders may share common genetic variation with epilepsy.
Indeed, genetic studies of copy number variants (CNVs) have
shown that in some cases, the same CNV occurs in neuropsychiat-
ric illness and epilepsy. Several studies have demonstrated an
association between large rare recurrent CNVs and epilepsy,
autism, schizophrenia, mental retardation, and attention deﬁcit
hyperactivity disorder [40,41]. Of particular relevance is the
observation that an individual CNV can contribute risk to more
than one type of neuropsychiatric disorder. This has led to the
suggestion that schizophrenia, autism, and intellectual disability
may be rather overlapping phenotypes from shared disturbed
neural development [42].
There were 13 families with TLE: 7 families had features
consistent with mesial TLE (simple partial seizures with intense
feelings of deja vu at times associated with dizziness or nausea,
complex partial seizures with altered awareness and staring) and
6 families had autosomal dominant epilepsy with auditory
features (ADEAF) previously denoted as autosomal dominant
lateral temporal lobe epilepsy. An AD trait was deduced in 76.9% of
these families (Table 1). It is well known that ADEAF follows AD
inheritance with decreased penetrance. Thus, by analysing data
from 24 previously published families with ADEAF and mutations
in the leucin-rich glioma inactivated gene (LGI), Rosanoff and
Ottman found that the overall penetrance of the disorder was 67%
and did not vary according to mutation type or location in the gene
[43]. Hedera et al. reported a 4-generation Caucasian family in
A. Chentouf et al. / Seizure 31 (2015) 12–18 17which 11 living individuals had features consistent with mesial
TLE. Three unaffected family members had affected offspring,
suggesting AD inheritance with incomplete penetrance [44].
Juvenile myoclonic epilepsy (JME) was reported in 9 families.
Pedigrees were compatible with a probable AD inheritance in
3 families and AR in 4 families. In the remaining two families,
pedigree analysis suggested more than one possible mode of
inheritance. The exact type of inheritance in JME is currently not
known; the rare family and genetic studies indicate rather
contradictory modes: AD, AR, maternal or complex [45].
Three families had Progressive Myoclonic Epilepsy type 1
(EPM1) with AR pattern of inheritance. EPM1 or Unverricht–
Lundborg disease (ULD) is an AR neurodegenerative disorder
characterized by action- and stimulus-sensitive myoclonus, tonic-
clonic seizures, progressive cerebellar ataxia, preserved cognition,
and poor outcome. Mutations in the gene encoding cystatin B
(CSTB), a cysteine protease inhibitor, are responsible for the
primary defect underlying EPM1 [46].
In our study population, there were 9 families with GEFS+
phenotype. Five families showed an AD probable mode of
inheritance and two others an AR pattern. To our knowledge, all
GEFS+ families, described in OMIM (Online Mendelian Inheritance
in Man—http://www.ncbi.nlm.nih.gov/omim) database, exclusive-
ly show an AD mode of inheritance. Recently, Belhedi et al.
described the ﬁrst consanguineous GEFS+ Tunisian family with a
putative AR mode of inheritance, a transmission previously
described in a Moroccan consanguineous family, showing FS
and temporal lobe epilepsy phenotypes [47].
Only one family showed CAE with AR trait. Familial form of
typical childhood absence epilepsy with an AR mode of inheri-
tance was also reported in ﬁve Tunisian consanguineous families
[48]. Four of our families (10%) had syndromic epilepsy with
suggested autosomal recessive inheritance pointing to the signiﬁ-
cant role of consanguinity in the expression of rare recessive
variants.
5. Limitations of the study
Our study has several limitations including the relatively small
sample size. It was a clinic-based study and may not represent the
full spectrum of familial epilepsies. Furthermore, patient and
family recall of epilepsy carried an inherent risk of incompleteness
or inaccuracy.
Due to the unavailability of ictal EEG recording, we were unable
to classify seizure type in four patients with some atypical features.
6. Conclusion
This study conﬁrms that there are large families in the Algerian
population with multigenerational inheritance of familial epilepsy
and phenotypic heterogeneity.
Seizures are well controlled in most cases except in myoclonic
syndromes, which are more difﬁcult to deal with despite trials of
several antiepileptic drugs. Psychiatric disorders are often
associated with epilepsy suggesting possible common genetic
underpinnings.
Autosomal recessive mode of inheritance was proposed in 35%
of our cases of familial epilepsy. The higher rate of consanguineous
unions reported in our population probably contributes to the
genetic epilepsy types encountered.
Our cohort of families with epilepsy represents a valuable
resource for the identiﬁcation of novel epilepsy genes. Further,
molecular testing such as deep sequencing for rare variants could
be used to clarify the genetic basis of epilepsy in some of our
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